Subacute sclerosing panencephalitis : diagnosis and drug treatment options

Area of Science:

• Neurology
• Virology
• Immunology

Background:

• Subacute sclerosing panencephalitis (SSPE) is a chronic, progressive, and often fatal neurological disease.
• Its exact cause is unknown but is associated with mutant measles virus in the central nervous system (CNS).

Purpose of the Study:

• To review the diagnostic criteria and current therapeutic options for SSPE.
• To highlight the need for further research into more effective treatments.

Main Methods:

• Diagnosis relies on clinical presentation and elevated measles antibodies in cerebrospinal fluid (CSF).
• Supportive data come from electroencephalography, imaging, and CSF measles antibody synthesis rates.
• Brain biopsy is used when CSF studies are negative to detect viral markers.

Main Results:

• Intraventricular interferon-alfa and oral inosine pranobex have shown the highest rates of stabilization or improvement.
• No single treatment has proven consistently curative.

Conclusions:

• SSPE diagnosis requires a combination of clinical and laboratory findings.
• While some treatments offer modest benefits, further multicenter clinical trials are essential to develop more effective therapeutic regimens for SSPE.